Handelsbanken Fonder’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$940K Buy
17,000
+2,600
+18% +$144K ﹤0.01% 995
2025
Q1
$696K Sell
14,400
-3,200
-18% -$155K ﹤0.01% 1100
2024
Q4
$679K Buy
+17,600
New +$679K ﹤0.01% 1167